NCT02683915

Brief Summary

This study aims to determine the effect of therapeutic hypothermia on reducing AKI in term and late-preterm infants with hypoxic ischemic encephalopathy as estimated by measurment of serum(s) neutrophil gelatinase-associated lipocalin(NGAL) and serum (s) cystatin-C.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 17, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

April 3, 2018

Status Verified

April 1, 2018

Enrollment Period

1 year

First QC Date

February 3, 2016

Last Update Submit

April 1, 2018

Conditions

Keywords

Acute kidney injuryPerinatal asphyxiaTherapeutic hypothermiaSerum NGALSerum cystatin-C

Outcome Measures

Primary Outcomes (1)

  • Acute kidney injury

    A serum createnine-based modification of the Acute Kidney Injury Network criteria: Stage 0: No change in SCr, Stage 1:↑SCr 0.3 mg/dL or ↑SCr 150- \<200% from previous trough value, Stage 2: ↑ SCr 200- \<300% from previous trough value, Stage 3: ↑ SCr ≥300% from previous trough value, SCr 2.5 mg/dL, or dialysis

    15 days

Study Arms (2)

Therapeutic hypothermia

Infants in cooled group will be fitted a cooling cap (Olympic Medical Cool Care System, Olympic Medical) around the head for 72 h. infants will be nursed under a radiant overhead heater, which is servo-controlled to the infant's abdominal skin temperature and adjusted to maintain the rectal temperature at 33.5-34.5ºC. At the end of the 72 h cooling period, the infants will be slowly rewarmed at no more than 0•5ºC /h until their temperature become within normal temperature range (36.5-37.5ºC).

Procedure: Therapeutic hypothermia

Non-cooled group

Infants in the non-cooled group received the current standard of care and will be placed under radiant heaters or in incubators, which are servo-controlled according to the abdominal skin temperature to maintain the rectal temperature at 37.0± 0.2°C.

Interventions

Infants in cooled group will be fitted a cooling cap (Olympic Medical Cool Care System, Olympic Medical) around the head for 72 h. infants will be nursed under a radiant overhead heater, which is servo-controlled to the infant's abdominal skin temperature and adjusted to maintain the rectal temperature at 33.5-34.5ºC. At the end of the 72 h cooling period, the infants will be slowly rewarmed at no more than 0•5ºC /h until their temperature become within normal temperature range (36.5-37.5ºC).

Also known as: Cooling
Therapeutic hypothermia

Eligibility Criteria

Age30 Minutes - 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants will be enrolled into two groups either group 1(cooled group) if identified within 12 hours of age and admitted at hospital with a validated cooling facility or group 2(non cooled group) if identified older than 12 hours of age or admitted at hospital out of reach of a validated cooling facility (cooling still not governmentally submitted in Egypt at wide scale).

You may qualify if:

  • Full term newborn exposed to peri-natal asphyxia
  • Presented by signs of hypoxic ischemic encephalopathy (Sarnat grade II or III)

You may not qualify if:

  • Major intracranial haemorrhage
  • Birth weight less than 1800 g.
  • Major congenital anomalies including:
  • Chromosomal anomalies.
  • Congenital heart disease.
  • Congenital diaphragmatic hernia.
  • Congenital hydrocephalus and neural tube defects.
  • Intestinal atresia, tracheooesophageal fistulas, and omphalocele.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Children Hospital

Al Mansurah, El Dakahlya, 35111, Egypt

Location

Related Publications (1)

  • Nour I, Elmaghraby R, Shehata R, El-Refaey A, Aldomiaty H, Mosbah A, Shouman B, Nasef N. Selective head cooling and acute kidney injury in neonates with hypoxic ischemic encephalopathy. J Neonatal Perinatal Med. 2020;13(1):21-30. doi: 10.3233/NPM-180200.

MeSH Terms

Conditions

Hypoxia-Ischemia, BrainAcute Kidney Injury

Interventions

Hypothermia, InducedCool-Down Exercise

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

CryotherapyTherapeuticsPost-Exercise Recovery TechniquesPhysical Therapy ModalitiesRehabilitationExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of pediatrics

Study Record Dates

First Submitted

February 3, 2016

First Posted

February 17, 2016

Study Start

September 1, 2015

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

April 3, 2018

Record last verified: 2018-04

Locations